MedPath

Detection of Usability Errors of a Medical Device Zeneo®

Not Applicable
Completed
Conditions
Healthy Volunteers
Interventions
Other: using the demo version of a self-injector pen
Registration Number
NCT03808246
Lead Sponsor
University Hospital, Lille
Brief Summary

The research addresses the question of the number of participants needed to identify as many usability-induced errors as possible in the context of summative usability tests. The research addresses also the impact of the ecological validity of the test environment on the number of usability-induced errors uncovered.

Detailed Description

In order to determine how many participants must be recruited to detect 95% of the anticipated use errors, two groups of participants (naives or informed to the type of device under evaluation) will take part to usability test of a demo version of an auto injector pen in one of two test environments (realistic or laboratory-like). The combination of the 2 types of users and the two types of environment composes 4 arms.

By default, 15 participants will be recruited per arm (in conformity with usual guidelines). If, in a given group, 95% of anticipated errors are detected, no more participants will be recruited in the arm. Otherwise, 5 other participants will be recruited till the 95% threshold is reached with a maximum of 40 participants per group.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Able to use the device
  • Without previous experience of anaphylactic shock
  • Not taking a psychotropic drug
  • Without hearing impairment
  • Covered by social security
  • Who signed the consent form and the information letter
  • Who agree to conform to the procedure of the study -
Exclusion Criteria
  • Pregnant women
  • Vulnerable Persons
  • Persons under administrative supervision
  • Persons who are subject to a judicial protection measure
  • Persons who do not understand correctly French.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
informed/realistic environmentusing the demo version of a self-injector penThis arm includes included participants who are informed in terms of self-injector pens and who have been randomly attributed to the "realistic environment" condition of simulation. The intervention is "using the demo version of a self-injector pen".
naive/realistic environmentusing the demo version of a self-injector penThis arm includes included participants who are naive in terms of self-injector pens and who have been randomly attributed to the "realistic environment" condition of simulation. The intervention is "using the demo version of a self-injector pen".
informed/laboratory-like environmentusing the demo version of a self-injector penThis arm includes included participants who are informed in terms of self-injector pens and who have been randomly attributed to the "laboratory-like environment" condition of simulation. The intervention is "using the demo version of a self-injector pen".
naive/laboratory-like environmentusing the demo version of a self-injector penThis arm includes included participants who are naive in terms of self-injector pens and who have been randomly attributed to the "laboratory-like environment" condition of simulation. The intervention is "using the demo version of a self-injector pen".
Primary Outcome Measures
NameTimeMethod
For each arm, number of participants needed to uncover 95% of the use errors knownthrough study completion, an average of 6 months
Secondary Outcome Measures
NameTimeMethod
number of use errors uncovered per participantthrough study completion, an average of 6 months
number of unanticipated errors detectedthrough study completion, an average of 6 months
number of participants who detected a given errorthrough study completion, an average of 6 months

Trial Locations

Locations (1)

Usability Lab of CIC IT 1403

🇫🇷

Lille, Haut De France, France

© Copyright 2025. All Rights Reserved by MedPath